EUVIMEDEUVIMED entdecken
Open Access

Dapagliflozin Attenuates Pericardial Adipose Tissue–Derived Leptin‐Mediated Myocardial Remodeling in Obese Rats

Chaodi Luo, Wenjie Luo, Tingting Zheng iD, Ping Wang, Lifei Cao, Hui Luan, Yan Song iD, Xiyang Li, Gang Tian iD

Journal of the American Heart Association · 21.07.2026 · 15 (14)

DOI: 10.1161/jaha.125.048155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 21.07.2026. Verfasst von Chaodi Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Peripheral Vascular diseases First Affiliated Hospital of Xi'an Jiaotong University Xi'an People's Republic of China. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Leptin, Obesity. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The favorable cardiovascular effects of sodium–glucose co‐transporter 2 inhibitors in diabetes are well established, but their potential to ameliorate obesity‐related cardiac dysfunction remains unclear. Pericardial adipose tissue (PAT)‐derived adipocytokines, particularly leptin, contribute to obesity‐associated cardiac remodeling. We investigated the detrimental effects of PAT‐derived leptin on cardiac remodeling and whether dapagliflozin confers cardioprotection by reducing and counteracting PAT‐derived leptin in obese rodents.

Methods

Male Wistar rats, C57BL/6J mice, and ob/ob mice were fed a normal or high‐fat diet for 20 weeks, with or without dapagliflozin (1 mg/kg per day) for the final 8 weeks. PAT adipocytes from 8‐week‐old rats were isolated and induced to insulin resistance. Primary cardiac fibroblasts and cardiomyocytes were exposed to PAT‐conditioned medium, leptin antagonist, dapagliflozin (10 μM), reactive oxygen species scavenger N‐acetylcysteine (50 mM), pNaKtide (10 μM), Src inhibitor PP2 (10 μM). Na + ‐K + ‐ATPase expression and activity, mitochondrial membrane potential, and mitochondrial permeability transition pore opening were assessed.

Results

The intervention of dapagliflozin to high‐fat diet–fed Wistar rats could reduce body weight and improve metabolic disorders. Furthermore, dapagliflozin significantly alleviated the adipocyte hypertrophy of PAT, cardiac fibrosis and apoptosis, as well as the leptin production and secretion from PAT. In vitro, dapagliflozin inhibits the leptin production and secretion in insulin‐resistant adipocytes of PAT by regulating the phosphoinositide 3‐kinase/protein kinase B and extracellular signal‐regulated kinase 1/2 signaling pathway. Meanwhile, dapagliflozin could counteract the profibrotic effect of PAT‐derived leptin via inhibiting the signal transducer and activator of transcription 3–reactive oxygen species/Na + ‐K + ‐ATPase/Src oxidative stress loop signaling pathway. Meanwhile, dapagliflozin could also attenuate cardiomyocytes apoptosis induced by PAT‐derived leptin via suppressing Janus kinase 2/signal transducer and activator of transcription 3‐Bax and inhibiting reactive oxygen species/Na + ‐K + ‐ATPase/Src oxidative stress loop.

Conclusions

Dapagliflozin reduced PAT‐derived leptin via phosphoinositide 3‐kinase/protein kinase B and extracellular signal‐regulated kinase 1/2 signaling and mitigated PAT‐derived leptin‐induced myocardial fibrosis and apoptosis by inhibiting signal transducer and activator of transcription 3‐mediated reactive oxygen species/Na + ‐K + ‐ATPase/Src oxidative stress signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Benzhydryl CompoundsGlucosidesLeptinObesityVentricular RemodelingMyocytes, CardiacSodium-Glucose Transporter 2 InhibitorsAnimalsMaleRats, WistarEpicardial Adipose TissueMice, Inbred C57BLDisease Models, AnimalSignal TransductionRatsDiet, High-FatCells, CulturedFibrosis

Stichwörter der Autor:innen

Na+‐K+‐ATPasecardiac remodelingdapagliflozinleptinobesitypericardial adipose tissue

Substanzen

Benzhydryl CompoundsdapagliflozinGlucosidesLeptinSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Peripheral Vascular diseases First Affiliated Hospital of Xi'an Jiaotong University Xi'an People's Republic of China.
  • College of Clinical Medicine Shaanxi University of Chinese Medicine Xian Yang People's Republic of China.
  • Department of Cardiology First Affiliated Hospital of Xi'an Jiaotong University Xi'an People's Republic of China.
  • Department of Blood Purification First Affiliated Hospital of Xi'an Jiaotong University Xi'an People's Republic of China.
  • Department of Ultrasound First Affiliated Hospital of Xi'an Jiaotong University Xi'an People's Republic of China.

ORCID-Profile: Tingting Zheng, Yan Song, Gang Tian

Zitieren

APA

Luo, C., Luo, W., Zheng, T., Wang, P., Cao, L., Luan, H., Song, Y., Li, X., & Tian, G. (2026). Dapagliflozin Attenuates Pericardial Adipose Tissue–Derived Leptin‐Mediated Myocardial Remodeling in Obese Rats. Journal of the American Heart Association, 15(14). https://doi.org/10.1161/jaha.125.048155

Vancouver

Luo C, Luo W, Zheng T, Wang P, Cao L, Luan H, et al. Dapagliflozin Attenuates Pericardial Adipose Tissue–Derived Leptin‐Mediated Myocardial Remodeling in Obese Rats. Journal of the American Heart Association. 2026;15(14). doi:10.1161/jaha.125.048155

BibTeX
@article{Luo2026,
  author = {Luo, Chaodi and Luo, Wenjie and Zheng, Tingting and Wang, Ping and Cao, Lifei and Luan, Hui and Song, Yan and Li, Xiyang and Tian, Gang},
  title = {Dapagliflozin Attenuates Pericardial Adipose Tissue–Derived Leptin‐Mediated Myocardial Remodeling in Obese Rats},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {14},
  doi = {10.1161/jaha.125.048155}
}
Kostenlos starten →